Drugs / CKD-390
CKD-390
also known as
Bis-poc-pmpa aspartate · GS-4331 ASPARTATE · Tenofovir Disoproxil Aspartate · Tenofovir disoproxil component of stribild · Tenofovir disoproxil fumarate component of atripla · Tenofovir disoproxil fumarate component of cimduo · Tenofovir disoproxil fumarate component of complera · Tenofovir disoproxil fumarate component of delstrigo · +8 more
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02589457 | Oct → Dec 2015 | chronic hepatitis B virus infection | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02805738 | Apr 2016 → Nov 2017 | chronic hepatitis B virus infection | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
Evidence & citations 19 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKD-390 | “compare the safety and pharmacokinetics of CKD-390(Tenofovir Disoproxil Aspartate) and Viread® tablet(Tenofovir Disoproxil Fumarate)” NCT02589457 ↗ |
| Known as | Bis-poc-pmpa aspartate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | GS-4331 ASPARTATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir Disoproxil Aspartate | “Tenofovir Disoproxil Aspartate 1T PO” NCT02589457 ↗ |
| Known as | Tenofovir disoproxil component of stribild | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir disoproxil fumarate component of atripla | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir disoproxil fumarate component of cimduo | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir disoproxil fumarate component of complera | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir disoproxil fumarate component of delstrigo | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir disoproxil fumarate component of eviplera | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir disoproxil fumarate component of odefsey | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir disoproxil fumarate component of stribild | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir disoproxil fumarate component of symfi | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir disoproxil fumarate component of temixys | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir disoproxil fumarate component of truvada | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir disoproxil mylan | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Known as | Tenofovir disoproxil zentiva | ChEMBL registry synonym — accepted as the source's own label CHEMBL1538 ↗ |
| Modality | Small molecule | — CHEMBL1538 ↗ |
| Route | Oral | “Tenofovir Disoproxil Aspartate 1T PO” NCT02589457 ↗ |